Trials of aliskiren for CAD and otamixaban for NSTE-ACS, chronic care management for substance dependence, and more.
Sep 17, 2013
13:34
forum Ask episode
view_agenda Chapters
auto_awesome Transcript
info_circle Episode notes
Editor's Audio Summary by Phil B. Fontanarosa, MD, MBA, Executive Editor, the Journal of the American Medical Association, for the September 18, 2013 issue